CN101511185A - 唑类核苷和作为rna和dna病毒聚合酶抑制剂的用途 - Google Patents
唑类核苷和作为rna和dna病毒聚合酶抑制剂的用途 Download PDFInfo
- Publication number
- CN101511185A CN101511185A CNA2007800337456A CN200780033745A CN101511185A CN 101511185 A CN101511185 A CN 101511185A CN A2007800337456 A CNA2007800337456 A CN A2007800337456A CN 200780033745 A CN200780033745 A CN 200780033745A CN 101511185 A CN101511185 A CN 101511185A
- Authority
- CN
- China
- Prior art keywords
- aryl
- virus
- alkyl
- compound
- cycloalkyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- WKMCMNCFKXZZNO-ARXGFGQCSA-N CC(c1n[n]([C@@H](C2O)O[C@H](CO)C2O)cn1)O Chemical compound CC(c1n[n]([C@@H](C2O)O[C@H](CO)C2O)cn1)O WKMCMNCFKXZZNO-ARXGFGQCSA-N 0.000 description 2
- AALNGYWGJZSWAL-SEZDTBSWSA-N C#Cc1c[n]([C@@H](C2O)O[C@H](CO)C2O)cn1 Chemical compound C#Cc1c[n]([C@@H](C2O)O[C@H](CO)C2O)cn1 AALNGYWGJZSWAL-SEZDTBSWSA-N 0.000 description 1
- WTEXBKLUDHNRBO-QIEYWLDOSA-N C#Cc1n[n]([C@@H](C2)O[C@H](CO)C2O)cn1 Chemical compound C#Cc1n[n]([C@@H](C2)O[C@H](CO)C2O)cn1 WTEXBKLUDHNRBO-QIEYWLDOSA-N 0.000 description 1
- FFCPOVBPJGWZTB-SEZDTBSWSA-N C#Cc1n[n]([C@@H](C2O)O[C@H](CO)C2O)cc1 Chemical compound C#Cc1n[n]([C@@H](C2O)O[C@H](CO)C2O)cc1 FFCPOVBPJGWZTB-SEZDTBSWSA-N 0.000 description 1
- ZCYWFUPNZBYYLW-WFXDJJTDSA-N C#Cc1n[n]([C@@H](C2O)O[C@H](CO)C2O)cn1 Chemical compound C#Cc1n[n]([C@@H](C2O)O[C@H](CO)C2O)cn1 ZCYWFUPNZBYYLW-WFXDJJTDSA-N 0.000 description 1
- KUPGPAYHPSGJDY-LVHTXCCMSA-N CC(C1=NN([C@@H](C2O)O[C@H](CO)C2O)[I]=N1)=O Chemical compound CC(C1=NN([C@@H](C2O)O[C@H](CO)C2O)[I]=N1)=O KUPGPAYHPSGJDY-LVHTXCCMSA-N 0.000 description 1
- UTYDRLUTPGVZST-DPYQTVNSSA-N CC(C1=NN([C@@H]([C@H]2O)O[C@H](CO)[C@@H]2O)[I]=N1)(F)F Chemical compound CC(C1=NN([C@@H]([C@H]2O)O[C@H](CO)[C@@H]2O)[I]=N1)(F)F UTYDRLUTPGVZST-DPYQTVNSSA-N 0.000 description 1
- WJYMYODOUSNDBA-SZDPNDIZSA-N CC(c1n[n]([C@@H](C2O)O[C@H](CO)C2O)cn1)=O Chemical compound CC(c1n[n]([C@@H](C2O)O[C@H](CO)C2O)cn1)=O WJYMYODOUSNDBA-SZDPNDIZSA-N 0.000 description 1
- SXPSYVCLNUJMDQ-NHSUTOTLSA-N C[n]1ncc(-c2n[n]([C@@H](C3O)O[C@H](CO)C3O)cn2)c1 Chemical compound C[n]1ncc(-c2n[n]([C@@H](C3O)O[C@H](CO)C3O)cn2)c1 SXPSYVCLNUJMDQ-NHSUTOTLSA-N 0.000 description 1
- NMLAEVCPOMRRBS-YYNZZODZSA-N NC(CC(c1n[n]([C@@H](C2O)O[C@H](CO)C2O)cn1)O)=O Chemical compound NC(CC(c1n[n]([C@@H](C2O)O[C@H](CO)C2O)cn1)O)=O NMLAEVCPOMRRBS-YYNZZODZSA-N 0.000 description 1
- NMLAEVCPOMRRBS-QKMHZUOUSA-N NC(CC(c1n[n]([C@@H]([C@H]2O)O[C@H](CO)[C@@H]2O)cn1)O)=O Chemical compound NC(CC(c1n[n]([C@@H]([C@H]2O)O[C@H](CO)[C@@H]2O)cn1)O)=O NMLAEVCPOMRRBS-QKMHZUOUSA-N 0.000 description 1
- RKHLORPGFZEROS-HGOJYGERSA-N Nc1c(C(Nc2cc(F)ccc2)=O)nc[n]1[C@@H](C1O)O[C@H](CO)C1O Chemical compound Nc1c(C(Nc2cc(F)ccc2)=O)nc[n]1[C@@H](C1O)O[C@H](CO)C1O RKHLORPGFZEROS-HGOJYGERSA-N 0.000 description 1
- VLUNBVMLEONAFY-HGOJYGERSA-N Nc1c(C(Nc2cc([N+]([O-])=O)ccc2)=O)nc[n]1[C@@H](C1O)O[C@H](CO)C1O Chemical compound Nc1c(C(Nc2cc([N+]([O-])=O)ccc2)=O)nc[n]1[C@@H](C1O)O[C@H](CO)C1O VLUNBVMLEONAFY-HGOJYGERSA-N 0.000 description 1
- OWTPVCKOAYUSOR-TYZXPVIJSA-N OCC(O[C@H](C1O)[n]2nc(C(c3ccccc3)=O)nc2)=C1O Chemical compound OCC(O[C@H](C1O)[n]2nc(C(c3ccccc3)=O)nc2)=C1O OWTPVCKOAYUSOR-TYZXPVIJSA-N 0.000 description 1
- KABCUCVEWIJHPZ-NPDIDSPYSA-N OC[C@H](C(C1O)O)O[C@H]1[n]1nc(-c2c[nH]nc2)nc1 Chemical compound OC[C@H](C(C1O)O)O[C@H]1[n]1nc(-c2c[nH]nc2)nc1 KABCUCVEWIJHPZ-NPDIDSPYSA-N 0.000 description 1
- WPXKJDDWIXVSHL-NPDIDSPYSA-N OC[C@H](C(C1O)O)O[C@H]1[n]1nc(-c2ccn[nH]2)nc1 Chemical compound OC[C@H](C(C1O)O)O[C@H]1[n]1nc(-c2ccn[nH]2)nc1 WPXKJDDWIXVSHL-NPDIDSPYSA-N 0.000 description 1
- WVKYTWZGOHGGDE-SZDPNDIZSA-N OC[C@H](C(C1O)O)O[C@H]1[n]1nc(-c2cnn[nH]2)nc1 Chemical compound OC[C@H](C(C1O)O)O[C@H]1[n]1nc(-c2cnn[nH]2)nc1 WVKYTWZGOHGGDE-SZDPNDIZSA-N 0.000 description 1
- ROHLPEVLNMRUIY-XTNGTSSOSA-N OC[C@H](C(C1O)O)O[C@H]1[n]1nc(C(C(F)(F)F)O)nc1 Chemical compound OC[C@H](C(C1O)O)O[C@H]1[n]1nc(C(C(F)(F)F)O)nc1 ROHLPEVLNMRUIY-XTNGTSSOSA-N 0.000 description 1
- YCRQMXYXFMTYIW-FMJARGGBSA-N OC[C@H](C(C1O)O)O[C@H]1[n]1nc(C(c2ccccc2)O)nc1 Chemical compound OC[C@H](C(C1O)O)O[C@H]1[n]1nc(C(c2ccccc2)O)nc1 YCRQMXYXFMTYIW-FMJARGGBSA-N 0.000 description 1
- RGEOJODIOVQFQB-WDEREUQCSA-N OC[C@H](CC1)O[C@H]1N1[I]=NC(C(c2ccccc2)=O)=N1 Chemical compound OC[C@H](CC1)O[C@H]1N1[I]=NC(C(c2ccccc2)=O)=N1 RGEOJODIOVQFQB-WDEREUQCSA-N 0.000 description 1
- MEWVGOZIUGGNPZ-LAGVYOHYSA-N OC[C@H](CC1)O[C@H]1[n]1nc(C(c2ccccc2)O)nc1 Chemical compound OC[C@H](CC1)O[C@H]1[n]1nc(C(c2ccccc2)O)nc1 MEWVGOZIUGGNPZ-LAGVYOHYSA-N 0.000 description 1
- KHFVSLJXUUKBHA-UHFFFAOYSA-N OCc([o]c(-[n]1nc(C(C(F)(F)F)=O)nc1)c1O)c1O Chemical compound OCc([o]c(-[n]1nc(C(C(F)(F)F)=O)nc1)c1O)c1O KHFVSLJXUUKBHA-UHFFFAOYSA-N 0.000 description 1
- AJVAAXDYQSXBCR-UHFFFAOYSA-N OCc([o]c(-[n]1nc(C[NH+]=[I-])nc1)c1O)c1O Chemical compound OCc([o]c(-[n]1nc(C[NH+]=[I-])nc1)c1O)c1O AJVAAXDYQSXBCR-UHFFFAOYSA-N 0.000 description 1
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H5/00—Compounds containing saccharide radicals in which the hetero bonds to oxygen have been replaced by the same number of hetero bonds to halogen, nitrogen, sulfur, selenium, or tellurium
- C07H5/04—Compounds containing saccharide radicals in which the hetero bonds to oxygen have been replaced by the same number of hetero bonds to halogen, nitrogen, sulfur, selenium, or tellurium to nitrogen
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
- A61K31/7056—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing five-membered rings with nitrogen as a ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
- C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
- C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
- C07H19/044—Pyrrole radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
- C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
- C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
- C07H19/056—Triazole or tetrazole radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H5/00—Compounds containing saccharide radicals in which the hetero bonds to oxygen have been replaced by the same number of hetero bonds to halogen, nitrogen, sulfur, selenium, or tellurium
- C07H5/04—Compounds containing saccharide radicals in which the hetero bonds to oxygen have been replaced by the same number of hetero bonds to halogen, nitrogen, sulfur, selenium, or tellurium to nitrogen
- C07H5/06—Aminosugars
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Molecular Biology (AREA)
- Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- Biotechnology (AREA)
- Genetics & Genomics (AREA)
- Virology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Pulmonology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Saccharide Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
Description
Claims (19)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US84339806P | 2006-09-11 | 2006-09-11 | |
US60/843,398 | 2006-09-11 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN101511185A true CN101511185A (zh) | 2009-08-19 |
Family
ID=39468551
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CNA2007800337456A Pending CN101511185A (zh) | 2006-09-11 | 2007-09-11 | 唑类核苷和作为rna和dna病毒聚合酶抑制剂的用途 |
Country Status (11)
Country | Link |
---|---|
US (1) | US20100129317A1 (zh) |
EP (1) | EP2061316A4 (zh) |
JP (1) | JP2010502748A (zh) |
KR (1) | KR20090094800A (zh) |
CN (1) | CN101511185A (zh) |
AU (1) | AU2007325551A1 (zh) |
CA (1) | CA2663618A1 (zh) |
EA (1) | EA016830B1 (zh) |
IL (1) | IL197415A0 (zh) |
MX (1) | MX2009002707A (zh) |
WO (1) | WO2008067002A2 (zh) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB0714649D0 (en) * | 2007-07-27 | 2007-09-05 | Univ Leuven Kath | Novel viral replication inhibitors |
EP2113508A1 (en) * | 2008-04-30 | 2009-11-04 | INSERM (Institut National de la Santé et de la Recherche Medicale) | Novel triazole nucleoside derivatives, their preparation and their application in therapeutics |
GB0815968D0 (en) * | 2008-09-03 | 2008-10-08 | Angeletti P Ist Richerche Bio | Antiviral agents |
WO2012051570A1 (en) | 2010-10-15 | 2012-04-19 | Shanta Bantia | Methods and compositions for inhibition of polymerase |
AR090699A1 (es) | 2012-04-18 | 2014-12-03 | Biocryst Pharm Inc | Compuestos inhibidores de la actividad de la arn polimerasa viral |
WO2017155886A1 (en) | 2016-03-06 | 2017-09-14 | Biocryst Pharmaceuticals, Inc. | Methods and compositions for treatment of zika virus infection |
Family Cites Families (26)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3968103A (en) * | 1972-09-28 | 1976-07-06 | Icn Pharmaceuticals, Inc. | 1,2,3-Triazole nucleosides |
JPS6426593A (en) * | 1987-07-21 | 1989-01-27 | Asahi Glass Co Ltd | Nucleoside derivative |
US4925930A (en) * | 1988-11-02 | 1990-05-15 | Nucleic Acid Research Institute | Synthesis and anti-leukemic activity of alkyl-1-(β-D-ribofuranosyl)[1,2,4]triazole-3-carboximidates |
US4992426A (en) * | 1989-02-27 | 1991-02-12 | Nucleic Acid Research Institute | Antiparasitic 5'-sulfamoyl nucleosides |
US6783931B1 (en) * | 1990-01-11 | 2004-08-31 | Isis Pharmaceuticals, Inc. | Amine-derivatized nucleosides and oligonucleosides |
US6339066B1 (en) * | 1990-01-11 | 2002-01-15 | Isis Pharmaceuticals, Inc. | Antisense oligonucleotides which have phosphorothioate linkages of high chiral purity and which modulate βI, βII, γ, δ, Ε, ζ and η isoforms of human protein kinase C |
US6060592A (en) * | 1990-01-11 | 2000-05-09 | Isis Pharmaceuticals, Inc. | Pyrimidine nucleoside compounds and oligonucleoside compounds containing same |
US6358931B1 (en) * | 1990-01-11 | 2002-03-19 | Isis Pharmaceuticals, Inc. | Compositions and methods for modulating RNA |
US6153737A (en) * | 1990-01-11 | 2000-11-28 | Isis Pharmaceuticals, Inc. | Derivatized oligonucleotides having improved uptake and other properties |
US7037646B1 (en) * | 1990-01-11 | 2006-05-02 | Isis Pharmaceuticals, Inc. | Amine-derivatized nucleosides and oligonucleosides |
US5777100A (en) * | 1990-08-10 | 1998-07-07 | Gensia Inc. | AICA riboside analogs |
US6262241B1 (en) * | 1990-08-13 | 2001-07-17 | Isis Pharmaceuticals, Inc. | Compound for detecting and modulating RNA activity and gene expression |
CA2133355A1 (en) * | 1993-10-04 | 1995-04-05 | Itaru Nitta | Method for producing polypeptide |
US5767097A (en) * | 1996-01-23 | 1998-06-16 | Icn Pharmaceuticals, Inc. | Specific modulation of Th1/Th2 cytokine expression by ribavirin in activated T-lymphocytes |
GB9602028D0 (en) * | 1996-02-01 | 1996-04-03 | Amersham Int Plc | Nucleoside analogues |
HUP0001107A3 (en) * | 1996-10-16 | 2003-01-28 | Icn Pharmaceuticals Inc Costa | Monocyclic l-nucleosides, analogs and pharmaceutical compositions thereof |
US6312662B1 (en) * | 1998-03-06 | 2001-11-06 | Metabasis Therapeutics, Inc. | Prodrugs phosphorus-containing compounds |
US6277830B1 (en) * | 1998-10-16 | 2001-08-21 | Schering Corporation | 5′-amino acid esters of ribavirin and the use of same to treat hepatitis C with interferon |
EP1244356A4 (en) * | 1999-12-23 | 2003-03-19 | Icn Pharmaceuticals | COMPOSITIONS AND METHODS RELATING TO NUCLEOSIDES-L, NUCLEOTIDES-L AND THEIR ANALOGS |
US6495677B1 (en) * | 2000-02-15 | 2002-12-17 | Kanda S. Ramasamy | Nucleoside compounds |
FR2810322B1 (fr) * | 2000-06-14 | 2006-11-10 | Pasteur Institut | PRODUCTION COMBINATOIRE D'ANALOGUES DE NUCLEOTIDES ET NUCLEOTIDES (XiTP) |
US6900298B2 (en) * | 2002-02-12 | 2005-05-31 | Mitsubishi Chemical Corporation | Process for producing nucleic acid derivative |
WO2003073989A2 (en) * | 2002-02-28 | 2003-09-12 | Biota, Inc. | Nucleoside 5'-monophosphate mimics and their prodrugs |
WO2004084796A2 (en) * | 2003-03-28 | 2004-10-07 | Pharmasset Ltd. | Compounds for the treatment of flaviviridae infections |
CA2537849A1 (en) * | 2003-09-11 | 2005-03-17 | F. Hoffmann-La Roche Ag | Process for preparing antiviral nucleoside derivatives |
US7348146B2 (en) * | 2003-10-02 | 2008-03-25 | Epoch Biosciences, Inc. | Single nucleotide polymorphism analysis of highly polymorphic target sequences |
-
2007
- 2007-09-11 CN CNA2007800337456A patent/CN101511185A/zh active Pending
- 2007-09-11 KR KR1020097005086A patent/KR20090094800A/ko not_active Application Discontinuation
- 2007-09-11 AU AU2007325551A patent/AU2007325551A1/en not_active Abandoned
- 2007-09-11 US US12/440,697 patent/US20100129317A1/en not_active Abandoned
- 2007-09-11 WO PCT/US2007/078139 patent/WO2008067002A2/en active Application Filing
- 2007-09-11 EA EA200970261A patent/EA016830B1/ru not_active IP Right Cessation
- 2007-09-11 CA CA002663618A patent/CA2663618A1/en not_active Abandoned
- 2007-09-11 EP EP07871070A patent/EP2061316A4/en not_active Withdrawn
- 2007-09-11 JP JP2009527620A patent/JP2010502748A/ja active Pending
- 2007-09-11 MX MX2009002707A patent/MX2009002707A/es not_active Application Discontinuation
-
2009
- 2009-03-05 IL IL197415A patent/IL197415A0/en unknown
Also Published As
Publication number | Publication date |
---|---|
KR20090094800A (ko) | 2009-09-08 |
WO2008067002A3 (en) | 2008-11-06 |
JP2010502748A (ja) | 2010-01-28 |
EA200970261A1 (ru) | 2010-02-26 |
EP2061316A4 (en) | 2011-08-24 |
EP2061316A2 (en) | 2009-05-27 |
CA2663618A1 (en) | 2008-06-05 |
WO2008067002A8 (en) | 2008-09-12 |
US20100129317A1 (en) | 2010-05-27 |
MX2009002707A (es) | 2009-11-26 |
IL197415A0 (en) | 2009-12-24 |
EA016830B1 (ru) | 2012-07-30 |
WO2008067002A2 (en) | 2008-06-05 |
AU2007325551A1 (en) | 2008-06-05 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN100560073C (zh) | 用于治疗病毒感染的n4-酰基胞嘧啶核苷 | |
JP6757294B2 (ja) | フィロウイルス科ウイルス感染症を処置するための方法 | |
CA2969372C (en) | Phosphoramidates for the treatment of hepatitis b virus | |
TWI519515B (zh) | B型肝炎抗病毒劑 | |
JP4980059B2 (ja) | 抗ウイルスヌクレオシド類似体およびウイルス感染特にhiv感染の処置方法 | |
US8895531B2 (en) | 2′-fluoronucleoside phosphonates as antiviral agents | |
KR20200140274A (ko) | 4'-할로겐 함유 뉴클레오티드 및 뉴클레오시드 치료 조성물 및 이와 관련된 용도 | |
NO342571B1 (no) | Fosfonatanaloger til HIV-inhibitorsammensetninger | |
TW201141488A (en) | Antiviral nucleosides | |
CA3029315A1 (en) | Phosphoramidates for the treatment of hepatitis b virus | |
TW201542581A (zh) | 核苷酸與核苷治療組成物及其相關用途 | |
CA2818853A1 (en) | 2'-spirocyclo-nucleosides for use in therapy of hcv or dengue virus | |
EP2828277A1 (en) | Solid forms of a thiophosphoramidate nucleotide prodrug | |
BG60679B1 (bg) | Аналози на 1,3-оксатиоланнуклеозида | |
CN101511185A (zh) | 唑类核苷和作为rna和dna病毒聚合酶抑制剂的用途 | |
CN104119385B (zh) | 核苷类似物的磷酸酯前药及其应用 | |
Abu-Zaied et al. | Sofosbuvir thio-analogues: synthesis and antiviral evaluation of the first novel pyridine-and pyrimidine-based thioglycoside phosphoramidates | |
US20190085013A1 (en) | Nucleotide and nucleoside therapeutic compositions and uses related thereto | |
JP2022106920A (ja) | アルキン含有ヌクレオチド及びヌクレオシド治療組成物並びにそれらに関連した使用 | |
US20120136017A1 (en) | Use of 4'-thio-2'-deoxynucleosides as anti orthopoxvirus agents | |
CA2826505A1 (en) | Antiviral nucleosides | |
KR20040054775A (ko) | 뉴클레오시드, 그들의 조합약과 알앤에이 바이러스성폴리머라제의 억제제로서의 사용방법 | |
Meppen et al. | Cyclic phosphoramidates as prodrugs of 2′-C-methylcytidine | |
CN107820499A (zh) | 新的抗病毒化合物、其制备工艺、以及其用于治疗病毒感染的用途 | |
US11618765B2 (en) | Broad-spectrum antiviral nucleoside derivatives |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
ASS | Succession or assignment of patent right |
Owner name: ARROW CENTRE CO., LTD. Free format text: FORMER OWNER: NEW MEXICO STATE UNIVERSITY |
|
C41 | Transfer of patent application or patent right or utility model | ||
TA01 | Transfer of patent application right |
Effective date of registration: 20101122 Address after: alabama Applicant after: Southern Research Inst. Co-applicant after: Arrowhead Ct Inc. Address before: alabama Applicant before: Southern Research Inst. Co-applicant before: New Mexico State University |
|
C02 | Deemed withdrawal of patent application after publication (patent law 2001) | ||
WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20090819 |